Do Latest SURPASS Findings With Twincretin in Diabetes Impress?
SURPASS-5 is latest published trial of a novel investigational once-weekly twincretin drug; editorialist says it leaves a number of unanswered questions about how best to use tirzepatide, if approved. Medscape Medical News